ORIGINAL RESEARCH

Ethics of research practice in clinical medicine

Ziganshina LE1,2,3, Ziganshin AU2
About authors

1 Russian Medical Academy of Continuous Professional Education, Moscow, Russia

2 Kazan State Medical University, Kazan, Russia

3 Рeoples’ Friendship University of Russia (RUDN University), Moscow, Russia

Correspondence should be addressed: Liliya E. Ziganshina
ul. Barrikadnaya, 2/1, b. 1, Moscow, 125993, Russia; moc.liamg@ngizel

About paper

Author contribution: Ziganshina LE — selection and analysis of literature, text writing; Ziganshin AU — literature analysis, text editing.

Received: 2023-02-07 Accepted: 2023-03-05 Published online: 2023-03-13
|

A half a century ago Archibald Cochrane, British physician and researcher, emphasized the necessity for critical assessment and a more elaborated approach to biomedical research results. Evidence-based medicine, which is designed to protect a patient from using scientifically unjustified technologies in healthcare, was widely developed subsequently. However, it soon became evident that numerous essential scientific researches contain a substantial proportion of costly but less informative and unjustified trials. They do not add any significant knowledge (wastes or unnecessary spending in research). In 2014, like-minded investigators have joined together in the international community of Evidence-based research. They suggested a plan of actions and algorithm for evidence-based research denoting the liability of all subjects. It is essential that the processes were under supervision of the scientific and medical society.

Keywords: clinical trials, ethics, novel medicines, Cochrane

КОММЕНТАРИИ (0)